Lipid nanoparticles: Formulations Beyond the Vaccine
Exploring the details behind one of the most talked-about technologies of the moment.
Lipid nanoparticles have gained a lot of attention against the backdrop of their landmark usage to fight against the COVID-19 pandemic. However, this usage is far from the full potential of this technology which, if realised, could have a major impact on our ability to deliver targeted therapies within the body. This report will lift the lid on the preclinical developments striving to address the various challenges facing this technology, as well as the underlying numbers behind LNP in the clinic.
Included in this report:
- Beacon analysis of LNP assets and their progress through the drug development pipeline
- A statistical breakdown of the various diseases being targeted and modalities making use of LNP technology
- Key innovations occurring to overcome various remaining challenges for LNPs, including that of extrahepatic delivery and LNP immunogenicity
To download your copy of the full report, please submit the details using the form on the right. A copy of the report will automatically download after submission.
Do you have a future market research project that you’d like to discuss with us?